+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Market Research Reports

From
From
From
Esmolol (CAS 103598-03-4) Global Market Research Report 2024 - Product Thumbnail Image

Esmolol (CAS 103598-03-4) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Ephedrine (CAS 299-42-3) Global Market Research Report 2024 - Product Thumbnail Image

Ephedrine (CAS 299-42-3) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Droxidopa (CAS 23651-95-8) Global Market Research Report 2024 - Product Thumbnail Image

Droxidopa (CAS 23651-95-8) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Dipyridamole (CAS 58-32-2) Global Market Research Report 2024 - Product Thumbnail Image

Dipyridamole (CAS 58-32-2) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
DL-Ephedrine (CAS 90-81-3) Global Market Research Report 2024 - Product Thumbnail Image

DL-Ephedrine (CAS 90-81-3) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
From
Enalapril (CAS 75847-73-3) Global Market Research Report 2024 - Product Thumbnail Image

Enalapril (CAS 75847-73-3) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
From
Dobutamine (CAS 34368-04-2) Global Market Research Report 2024 - Product Thumbnail Image

Dobutamine (CAS 34368-04-2) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Efloxate (CAS 119-41-5) Global Market Research Report 2024 - Product Thumbnail Image

Efloxate (CAS 119-41-5) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Doxazosin (CAS 74191-85-8) Global Market Research Report 2024 - Product Thumbnail Image

Doxazosin (CAS 74191-85-8) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Delapril (CAS 83435-66-9) Global Market Research Report 2024 - Product Thumbnail Image

Delapril (CAS 83435-66-9) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Digoxin (CAS 20830-75-5) Global Market Research Report 2024 - Product Thumbnail Image

Digoxin (CAS 20830-75-5) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Cymarin (CAS 508-77-0) Global Market Research Report 2024 - Product Thumbnail Image

Cymarin (CAS 508-77-0) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Loading Indicator

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more